Adaolisa Anaka, PharmD, BCACP, AAHIVP, discusses a pharmacist-led model that targets access barriers to GLP-1 obesity therapy.
Adaolisa Anaka, PharmD, BCACP, AAHIVP
Advertisement
Articles by Adaolisa Anaka, PharmD, BCACP, AAHIVP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Medicare Part D Ruxolitinib Spending Hits $49.6 Million as Use Surges
2
Surrogate End Points, Drug Costs Complicate Oncology Formularies
3
COVID-19 or Flu? Symptoms Alone Can't Tell: Tammy Lundstrom, MD, JD
4
Perceptions About CGMs Among Primary Care Physicians and Endocrinologists
5